Laser showdown: which prostate surgery technique is faster and safer?

NCT ID NCT06565741

Recruiting now Disease control Sponsor: Fundacio Puigvert Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This trial compares two laser methods (MoLEP and ThuFLEP) for removing prostate tissue in men with enlarged prostates (over 80cc). 120 men aged 40-90 who need surgery will be randomly assigned to one of the two lasers. The main goal is to see which technique is faster, while also checking for differences in bleeding, hospital stay, and symptom improvement.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Laser (Holmium or Thulium Fiber) for prostate surgery
What this could lead to: If successful, this could show which laser technique removes prostate tissue faster with less bleeding, improving surgical outcomes for men with enlarged prostates.
What could go wrong: This is a small, early-stage trial (120 participants) comparing two established techniques, so differences may be minor. Results may not apply to all surgeons or hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOSCOPIC ANATOMICAL ENUCLEATION OF THE PROSTATE (EEAP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ENDOSCOPIC ANATOMICAL ENUCLEATION OF THE PROSTATE (EEAP) PROSTATIC HYPERPLASIA SURGERY

Contacts and locations

Locations

Clinic Hospital of Barcelona
RECRUITING

Barcelona, BARCELONA, 08036, Spain
Fundacio Puigvert
RECRUITING

Barcelona, BARCELONA, 08025, Spain
Hospital Univesitari de Bellvitge
RECRUITING

L'Hospitalet de Llobregat, BARCELONA, 08907, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.